What is Pathcom Systems?
Pathcom Systems Corporation operates as a specialized manufacturer within the medical technology sector, maintaining rigorous ISO 13485:2016 and MDSAP certifications. The company distinguishes itself through the development of fully automated immunohistochemistry staining instruments, which are distributed primarily on an original equipment manufacturer (OEM) basis. By providing high-precision diagnostic tools, Pathcom Systems enables healthcare providers to streamline pathological examinations, thereby improving diagnostic accuracy and operational efficiency. Their business model focuses on high-quality production standards, positioning them as a critical infrastructure partner for larger medical diagnostic firms seeking reliable, automated laboratory solutions.
How much funding has Pathcom Systems raised?
Pathcom Systems has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Pathcom Systems
PPP
Public-Private Partnership
What's next for Pathcom Systems?
Following this major strategic investment, Pathcom Systems is well-positioned to scale its manufacturing capacity and deepen its penetration into the global pathology market. The infusion of capital will likely be directed toward enhancing R&D initiatives for next-generation staining technology and expanding the company's OEM partnership network. As the demand for automated diagnostic workflows continues to rise, Pathcom Systems is expected to leverage its regulatory compliance and technical expertise to capture additional market share, transitioning from a specialized manufacturer to a foundational pillar in the automated pathology ecosystem.
See full Pathcom Systems company page
